Difference between revisions of "Carnitine-acylcarnitine translocase"
From Bioblast
| Line 2: | Line 2: | ||
|abbr=CACT | |abbr=CACT | ||
|description='''Carnitine-acylcarnitine translocase''' (CACT) is part of the carnitine shuttle which mediates the mitochondrial transport of long-chain fatty acids where the [[fatty acid oxidation]] occurs. | |description='''Carnitine-acylcarnitine translocase''' (CACT) is part of the carnitine shuttle which mediates the mitochondrial transport of long-chain fatty acids where the [[fatty acid oxidation]] occurs. | ||
CACT is an internal mt-IM protein and transports | CACT is an internal mt-IM protein and transports [[acylcarnitine]]s into the mitochondrial matrix in exchange for free [[carnitine]]. | ||
|type= | |type= | ||
}} | }} | ||
Latest revision as of 16:48, 13 April 2023
- high-resolution terminology - matching measurements at high-resolution
Carnitine-acylcarnitine translocase
Description
Carnitine-acylcarnitine translocase (CACT) is part of the carnitine shuttle which mediates the mitochondrial transport of long-chain fatty acids where the fatty acid oxidation occurs. CACT is an internal mt-IM protein and transports acylcarnitines into the mitochondrial matrix in exchange for free carnitine.
Abbreviation: CACT
- The project FAT4BRAIN has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 857394
MitoPedia topics:
Enzyme
Labels:
MitoPedia:FAT4BRAIN
